Company page
Genexine, Inc.
Genexine, Inc. is a public company traded on the Korean stock market under the ticker 095700. The company has a market capitalization of approximately 84.76 million USD. Genexine focuses on biopharmaceutical development, aiming to create innovative therapies for various diseases.
- Ticker
- 095700:KRX
- Asset type
- Stock
- Market cap
- $84.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW